NCT00537056
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT02778243
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
- Locations
-
- Hopital Foch Suresnes, France
NCT01108055
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), +17 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
NCT01908166
- Conditions
- Adenocarcinoma, Adult Primary Liver Cancer, Carcinoma, +20 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
NCT03174912
- Conditions
- Bladder Cancer, Disease Attributes, Disease Progression, +15 more
- Locations
-
Not specified
Completed
Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer
NCT01189370
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States
Completed
Diode Laser Treatment of Bladder Tumors
NCT02738827
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Urological department, Frederiksberg Hospital Copenhagen, Denmark
NCT02150369
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
- Locations
-
- Duke University Hospital Durham, North Carolina, United States
NCT01138124
- Conditions
- Adenocarcinoma, Brain Diseases, Carcinoma, +55 more
- Locations
-
Not specified
Completed
Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
NCT00835978
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- East Bay Medical Oncology/Hematology Medical Associates Inc. Antioch, California, United States
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States
- Diablo Valley Oncology and Hematology Medical Group Inc Pleasant Hill, California, United States